Literature DB >> 32205183

A cardiomyocyte show of force: A fluorescent alpha-actinin reporter line sheds light on human cardiomyocyte contractility versus substrate stiffness.

Marcelo C Ribeiro1, Rolf H Slaats1, Verena Schwach1, José M Rivera-Arbelaez1, Leon G J Tertoolen2, Berend J van Meer2, Robert Molenaar3, Christine L Mummery4, Mireille M A E Claessens3, Robert Passier5.   

Abstract

Cardiovascular disease is often associated with cardiac remodeling, including cardiac fibrosis, which may lead to increased stiffness of the heart wall. This stiffness in turn may cause subsequent failure of cardiac myocytes, however the response of these cells to increased substrate stiffness is largely unknown. To investigate the contractile response of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) to increased substrate stiffness, we generated a stable transgenic human pluripotent stem cell line expressing a fusion protein of α-Actinin and fluorescent mRubyII in a previously characterized NKX2.5-GFP reporter line. Cardiomyocytes differentiated from this line were subjected to a substrate with stiffness ranging from 4 kPa to 101 kPa, while contraction of sarcomeres and bead displacement in the substrate were measured for each single cardiomyocyte. We found that sarcomere dynamics in hPSC-CMs on polyacrylamide gels of increasing stiffness are not affected above physiological levels (21 kPa), but that contractile force increases up to a stiffness of 90 kPa, at which cell shortening, deducted from bead displacement, is significantly reduced compared to physiological stiffness. We therefore hypothesize that this discrepancy may be the cause of intracellular stress that leads to hypertrophy and consequent heart failure in vivo.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alpha-actinin; Contractility; Substrate stiffness; Transgenic model

Mesh:

Substances:

Year:  2020        PMID: 32205183     DOI: 10.1016/j.yjmcc.2020.03.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

1.  Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction?

Authors:  Ilaria Stadiotti; Rosaria Santoro; Alessandro Scopece; Sergio Pirola; Anna Guarino; Gianluca Polvani; Angela Serena Maione; Flora Ascione; Qingsen Li; Domenico Delia; Marco Foiani; Giulio Pompilio; Elena Sommariva
Journal:  Front Cardiovasc Med       Date:  2022-06-23

2.  Conventional rigid 2D substrates cause complex contractile signals in monolayers of human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Eline Huethorst; Peter Mortensen; Radostin D Simitev; Hao Gao; Lotta Pohjolainen; Virpi Talman; Heikki Ruskoaho; Francis L Burton; Nikolaj Gadegaard; Godfrey L Smith
Journal:  J Physiol       Date:  2021-12-07       Impact factor: 6.228

3.  Measuring Both pH and O2 with a Single On-Chip Sensor in Cultures of Human Pluripotent Stem Cell-Derived Cardiomyocytes to Track Induced Changes in Cellular Metabolism.

Authors:  Esther Tanumihardja; Rolf H Slaats; Andries D van der Meer; Robert Passier; Wouter Olthuis; Albert van den Berg
Journal:  ACS Sens       Date:  2020-12-29       Impact factor: 7.711

4.  In Vitro Methods to Model Cardiac Mechanobiology in Health and Disease.

Authors:  Ignasi Jorba; Dylan Mostert; Leon H L Hermans; Atze van der Pol; Nicholas A Kurniawan; Carlijn V C Bouten
Journal:  Tissue Eng Part C Methods       Date:  2021-03-05       Impact factor: 3.056

Review 5.  Sensing and Responding of Cardiomyocytes to Changes of Tissue Stiffness in the Diseased Heart.

Authors:  Juliane Münch; Salim Abdelilah-Seyfried
Journal:  Front Cell Dev Biol       Date:  2021-02-26

6.  Multiplexing physical stimulation on single human induced pluripotent stem cell-derived cardiomyocytes for phenotype modulation.

Authors:  Worrapong Kit-Anan; Manuel M Mazo; Brian X Wang; Vincent Leonardo; Isaac J Pence; Sahana Gopal; Amy Gelmi; Anika Nagelkerke; Michele Becce; Ciro Chiappini; Sian E Harding; Cesare M Terracciano; Molly M Stevens
Journal:  Biofabrication       Date:  2021-03-12       Impact factor: 9.954

7.  A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues.

Authors:  Marcelo C Ribeiro; José M Rivera-Arbeláez; Carla Cofiño-Fabres; Verena Schwach; Rolf H Slaats; Simone A Ten Den; Kim Vermeul; Albert van den Berg; José M Pérez-Pomares; Loes I Segerink; Juan A Guadix; Robert Passier
Journal:  J Pers Med       Date:  2022-02-04

8.  Fluidic circuit board with modular sensor and valves enables stand-alone, tubeless microfluidic flow control in organs-on-chips.

Authors:  Aisen Vivas; Albert van den Berg; Robert Passier; Mathieu Odijk; Andries D van der Meer
Journal:  Lab Chip       Date:  2022-03-15       Impact factor: 6.799

Review 9.  Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.

Authors:  Kalina Andrysiak; Jacek Stępniewski; Józef Dulak
Journal:  Pflugers Arch       Date:  2021-02-24       Impact factor: 3.657

Review 10.  Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure.

Authors:  Anton Deicher; Timon Seeger
Journal:  Curr Heart Fail Rep       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.